Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Babloo Lukram"'
Autor:
Hans Skovgaard Poulsen, Kirsten Grunnet, Ulrik Lassen, Vibeke Andrée Larsen, Thomas Urup, Ib Jarle Christensen, Helle Broholm, Michael Kosteljanetz, Babloo Lukram, Signe Regner Michaelsen, Anders Toft
Publikováno v:
Cancer Investigation. 36:165-174
Predictive biomarkers and prognostic models are required to identify recurrent grade III glioma patients who benefit from existing treatment. In this study of 62 recurrent grade III glioma patients, a range of clinical and paraclinical factors are te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f836cdaa566accd6b334c5c1ea86369
https://doi.org/10.1080/07357907.2018.1430818
https://doi.org/10.1080/07357907.2018.1430818
Autor:
Babloo Lukram, Vibeke Andrée Larsen, Anders Toft, Hans Skovgaard Poulsen, Signe Regner Michaelsen, Kirsten Grunnet, Ib Jarle Christensen, Michael Kosteljanetz, Ulrik Lassen, Thomas Urup, Helle Broholm
Publikováno v:
Molecular Cancer Therapeutics. 14:B3-B3
BACKGROUND Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor A (VEGF-A), has demonstrated activity in the treatment of recurrent malignant glioma. High response rates have been observed, but particularly in WHO grade 3 g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f77eab5af1f5a7dd6d753f850ecc5367
https://doi.org/10.1158/1535-7163.targ-15-b3
https://doi.org/10.1158/1535-7163.targ-15-b3
Autor:
Hans Skovgaard Poulsen, Kirsten Grunnet, Ulrik Lassen, Vibeke André Larsen, Thomas Urup, Ib Jarle Christensen, Helle Broholm, Michael Kosteljanetz, Babloo Lukram, Signe Regner Michaelsen, Anders Toft
Publikováno v:
Neuro-Oncology. 17:v84.2-v84
BACKGROUND: Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor A (VEGF-A) has shown activity in the treatment of recurrent malignant glioma. Predictive markers and prognostic models are required in order to individualize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04278a7ac2b5ce7c2db39811453eeca
https://doi.org/10.1093/neuonc/nov213.28
https://doi.org/10.1093/neuonc/nov213.28